Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
Archivos espanoles de urologia(2)
Actas Urologicas Espanolas(1)
Arab Journal of Urology(1)
European Urology Open Science(1)
Minerva Urologica e Nefrologica(1)
Área de conocimiento
Medicina interna(1)
Origen
scopus(6)
Biomarcadores en el manejo del cáncer de próstata. ¿Hay algo nuevo?
ReviewAbstract: INTRODUCTION: Prostate cancer (PCa) diagnosis cornerstone has been prostate-specific antigen levelsPalabras claves:BIOMARCADOR, Biomarker, CÁNCER DE PRÓSTATA, DIÁGNOSTICO, Genetic assay, prognosis, Pronostico, Prostate cancer, screening, Test genéticoAutores:Alvarez-Maestro M., Diego M. Carrión, Martinez-Piñéiro L., Rivas J.G.Fuentes:scopusBone-targeted therapy in castration-resistant prostate cancer: Where do we stand?
ReviewAbstract: Introduction: In the last years, there have been significant developments in the therapeutic armamenPalabras claves:Denosumab, prostatic neoplasms, Radium-223, theranostic nanomedicine, Zoledronic acidAutores:Alvarez-Maestro M., Cathelineau X., Debruyne F., Diego M. Carrión, Lorenzo G.D., Maio M.D., Martinez-Piñéiro L., Paul A., Rivas J.G., Saad F., Sanchez-Salas R., Sartor O.Fuentes:scopusCáncer de próstata de alto riesgo. Tratamiento óptimo. Nuevas evidencias
ArticleAbstract: There are multiple definitions of high risk prostate cancer and each definition is associated with aPalabras claves:Alto riesgo, CÁNCER DE PRÓSTATA, High risk, management, New evidence, Nueva evidencia, Optimal treatment, Prostate cancer, tratamiento, Tratamiento óptimoAutores:Alvarez-Maestro M., Bazán A.A., Diego M. Carrión, Juarez Soto A., Martinez-Piñéiro L., Quesada-Olarte J.M., Rios González E., Rivas J.G.Fuentes:scopusNew strategies for decision making in prostate cancer. The role of oncotypedx
OtherAbstract:Palabras claves:Autores:Alvarez-Maestro M., Diego M. Carrión, Martinez-Piñéiro L., Rivas J.G., Toribio-Vázquez C., Yagüe Barrado M., Yebes A.Fuentes:scopusThe Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
ArticleAbstract: Background: There might be differential sensitivity to neoadjuvant chemotherapy (NAC) in patients wiPalabras claves:bladder cancer, Neoadjuvant chemotherapy, Primary, Response, Secondary, SurvivalAutores:Alvarez-Maestro M., Brönimann S., De Berardinis E., del Giudice F., Di Maida F., Di Trapani E., Diego M. Carrión, D’Andrea D., Filippot R., Grisay G., Hendricksen K., Krajewski W., Laukhtina E., Maggi M., Mari A., Mertens L.S., Moschini M., Paulnsteiner D., Pichler R., Pradere B., Shariat S.F., Soria F., Vallet S., van Rhijn B.W.G.Fuentes:scopusThe effect of neoadjuvant chemotherapy among patients undergoing radical cystectomy for variant histology bladder cancer: A systematic review
ReviewAbstract: Objective: To systematically review the evidence about the effect of neoadjuvant chemotherapy (NAC)Palabras claves:bladder cancer, Neoadjuvant chemotherapy, Radical cystectomy, Systematic Review, variant histology urothelial cancerAutores:Alvarez-Maestro M., Bazán A.A., Chierigo F., Diego M. Carrión, Mantica G., Martinez-Piñéiro L., Pinto-Marin A., Quesada-Olarte J.M., Rivas J.G.Fuentes:scopus